 | • レポートコード：20QY06-01073 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、エリスロポエチンのグローバル市場について種類別（エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他）、用途別（貧血、腎障害、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・エリスロポエチン市場の概要 ・世界の主要地域別エリスロポエチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のエリスロポエチン市場規模2015-2026：種類別（エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他） ・世界のエリスロポエチン市場規模2015-2026：用途別（貧血、腎障害、その他） ・エリスロポエチンの北米市場規模2015-2020 ・エリスロポエチンのヨーロッパ市場規模2015-2020 ・エリスロポエチンの中国市場規模2015-2020 ・エリスロポエチンの日本市場規模2015-2020 ・エリスロポエチンの東南アジア市場規模2015-2020 ・エリスロポエチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Amgen、Johnson & Johnson、Roche、Galenica、Emcure、Kyowa Hakko Kirin、3SBio、Biocon、LG Life Sciences） ・エリスロポエチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・エリスロポエチンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Erythropoietin Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Erythropoietin market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death.
In this report, we definite one unit for 1ml, except Epoetin-alfa type, which one unit means 10000units/ml
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Erythropoietin market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Erythropoietin industry.
Based on our recent survey, we have several different scenarios about the Erythropoietin YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 8146.7 million in 2019. The market size of Erythropoietin will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Erythropoietin market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Erythropoietin market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Erythropoietin market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Erythropoietin market. The report also includes nautical information, where it shows Erythropoietin market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Erythropoietin market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Erythropoietin market.
The classification of erythropoietin includes epoetin-alfa, epoetin-beta, darbepoetin-alfa and others. The proportion of epoetin-alfa in 2016 is about 58.53%.
Geographical Analysis:
Based on region, the global Erythropoietin market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Erythropoietin market are
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Segment by Type
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others
Segment by Application
Anemia
Kidney Disorders
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Erythropoietin market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Erythropoietin market.
• The market share of the global Erythropoietin market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Erythropoietin market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Erythropoietin market.
1 Erythropoietin Market Overview
1.1 Erythropoietin Product Scope
1.2 Erythropoietin Segment by Type
1.2.1 Global Erythropoietin Sales by Type (2020-2026)
1.2.2 Epoetin-alfa
1.2.3 Epoetin-beta
1.2.4 Darbepoetin-alfa
1.2.5 Others
1.3 Erythropoietin Segment by Application
1.3.1 Global Erythropoietin Sales Comparison by Application (2020-2026)
1.3.2 Anemia
1.3.3 Kidney Disorders
1.3.4 Others
1.4 Erythropoietin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Erythropoietin Sales Growth Rate (2015-2026)
1.4.2 Global Erythropoietin Revenue and Growth Rate (2015-2026)
1.4.3 Global Erythropoietin Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Erythropoietin Industry Impact
1.5.1 How the Covid-19 is Affecting the Erythropoietin Industry
1.5.1.1 Erythropoietin Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Erythropoietin Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Erythropoietin Players to Combat Covid-19 Impact
2 Erythropoietin Estimate and Forecast by Region
2.1 Global Erythropoietin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Erythropoietin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Erythropoietin Sales Market Share by Region (2015-2020)
2.2.2 Global Erythropoietin Revenue Market Share by Region (2015-2020)
2.3 Global Erythropoietin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Erythropoietin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Erythropoietin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Erythropoietin Estimates and Projections (2015-2026)
2.4.2 Europe Erythropoietin Estimates and Projections (2015-2026)
2.4.3 China Erythropoietin Estimates and Projections (2015-2026)
2.4.4 Japan Erythropoietin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Erythropoietin Estimates and Projections (2015-2026)
2.4.6 India Erythropoietin Estimates and Projections (2015-2026)
3 Global Erythropoietin Competition Landscape by Players
3.1 Global Top Erythropoietin Players by Sales (2015-2020)
3.2 Global Top Erythropoietin Players by Revenue (2015-2020)
3.3 Global Erythropoietin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erythropoietin as of 2019)
3.4 Global Erythropoietin Average Price by Company (2015-2020)
3.5 Manufacturers Erythropoietin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Erythropoietin Players (Opinion Leaders)
4 Global Erythropoietin Market Size by Type
4.1 Global Erythropoietin Historic Market Review by Type (2015-2020)
4.1.1 Global Erythropoietin Sales Market Share by Type (2015-2020)
4.1.2 Global Erythropoietin Revenue Market Share by Type (2015-2020)
4.1.3 Global Erythropoietin Price by Type (2014-2020)
4.2 Global Erythropoietin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Erythropoietin Sales Forecast by Type (2021-2026)
4.2.2 Global Erythropoietin Revenue Forecast by Type (2021-2026)
4.2.3 Global Erythropoietin Price Forecast by Type (2021-2026)
5 Global Erythropoietin Market Size by Application
5.1 Global Erythropoietin Historic Market Review by Application (2015-2020)
5.1.1 Global Erythropoietin Sales Market Share by Application (2015-2020)
5.1.2 Global Erythropoietin Revenue Market Share by Application (2015-2020)
5.1.3 Global Erythropoietin Price by Application (2015-2020)
5.2 Global Erythropoietin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Erythropoietin Sales Forecast by Application (2021-2026)
5.2.2 Global Erythropoietin Revenue Forecast by Application (2021-2026)
5.2.3 Global Erythropoietin Price Forecast by Application (2021-2026)
3 North America Erythropoietin Market Facts & Figures
3.2 North America Erythropoietin Sales Market Share by Company (2015-2020)
3.3 North America Erythropoietin Sales Market Share by Type (2015-2020)
3.4 North America Erythropoietin Sales Market Share by Application (2015-2020)
4 Europe Erythropoietin Market Facts & Figures
4.2 Europe Erythropoietin Sales Market Share by Company (2015-2020)
4.3 Europe Erythropoietin Sales Market Share by Type (2015-2020)
4.4 Europe Erythropoietin Sales Market Share by Application (2015-2020)
5 China Erythropoietin Market Facts & Figures
5.2 China Erythropoietin Sales Market Share by Company (2015-2020)
5.3 China Erythropoietin Sales Market Share by Type (2015-2020)
5.4 China Erythropoietin Sales Market Share by Application (2015-2020)
6 Japan Erythropoietin Market Facts & Figures
6.2 Japan Erythropoietin Sales Market Share by Company (2015-2020)
6.3 Japan Erythropoietin Sales Market Share by Type (2015-2020)
6.4 Japan Erythropoietin Sales Market Share by Application (2015-2020)
7 Southeast Asia Erythropoietin Market Facts & Figures
7.2 Southeast Asia Erythropoietin Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Erythropoietin Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Erythropoietin Sales Market Share by Application (2015-2020)
8 India Erythropoietin Market Facts & Figures
8.2 India Erythropoietin Sales Market Share by Company (2015-2020)
8.3 India Erythropoietin Sales Market Share by Type (2015-2020)
8.4 India Erythropoietin Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Erythropoietin Business
12.1 Amgen
12.1.1 Amgen Erythropoietin Corporation Information
12.1.2 Amgen Erythropoietin Business Overview and Total Revenue
12.1.3 Amgen Erythropoietin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Amgen Erythropoietin Products Offered
12.1.5 Amgen Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Erythropoietin Corporation Information
12.2.2 Johnson & Johnson Erythropoietin Business Overview and Total Revenue
12.2.3 Johnson & Johnson Erythropoietin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Johnson & Johnson Erythropoietin Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Roche
12.3.1 Roche Erythropoietin Corporation Information
12.3.2 Roche Erythropoietin Business Overview and Total Revenue
12.3.3 Roche Erythropoietin Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Roche Erythropoietin Products Offered
12.3.5 Roche Recent Development
12.4 Galenica
12.4.1 Galenica Erythropoietin Corporation Information
12.4.2 Galenica Erythropoietin Business Overview and Total Revenue
12.4.3 Galenica Erythropoietin Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Galenica Erythropoietin Products Offered
12.4.5 Galenica Recent Development
12.5 Emcure
12.5.1 Emcure Erythropoietin Corporation Information
12.5.2 Emcure Erythropoietin Business Overview and Total Revenue
12.5.3 Emcure Erythropoietin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Emcure Erythropoietin Products Offered
12.5.5 Emcure Recent Development
12.6 Kyowa Hakko Kirin
12.6.1 Kyowa Hakko Kirin Erythropoietin Corporation Information
12.6.2 Kyowa Hakko Kirin Erythropoietin Business Overview and Total Revenue
12.6.3 Kyowa Hakko Kirin Erythropoietin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Kyowa Hakko Kirin Erythropoietin Products Offered
12.6.5 Kyowa Hakko Kirin Recent Development
12.7 3SBio
12.7.1 3SBio Erythropoietin Corporation Information
12.7.2 3SBio Erythropoietin Business Overview and Total Revenue
12.7.3 3SBio Erythropoietin Sales, Revenue and Gross Margin (2015-2020)
12.7.4 3SBio Erythropoietin Products Offered
12.7.5 3SBio Recent Development
12.8 Biocon
12.8.1 Biocon Erythropoietin Corporation Information
12.8.2 Biocon Erythropoietin Business Overview and Total Revenue
12.8.3 Biocon Erythropoietin Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Biocon Erythropoietin Products Offered
12.8.5 Biocon Recent Development
12.9 LG Life Sciences
12.9.1 LG Life Sciences Erythropoietin Corporation Information
12.9.2 LG Life Sciences Erythropoietin Business Overview and Total Revenue
12.9.3 LG Life Sciences Erythropoietin Sales, Revenue and Gross Margin (2015-2020)
12.9.4 LG Life Sciences Erythropoietin Products Offered
12.9.5 LG Life Sciences Recent Development
13 Erythropoietin Manufacturing Cost Analysis
13.1 Erythropoietin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Erythropoietin
13.4 Erythropoietin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Erythropoietin Distributors List
14.3 Erythropoietin Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Erythropoietin Sales (M Units) Growth Rate by Type (2020-2026)
Table 2. Global Erythropoietin Sales (M Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Erythropoietin Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Erythropoietin Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Erythropoietin Players to Combat Covid-19 Impact
Table 8. Global Market Erythropoietin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Erythropoietin Sales (M Units) by Region (2015-2020)
Table 10. Global Erythropoietin Sales Market Share by Region (2015-2020)
Table 11. Global Erythropoietin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Erythropoietin Revenue Share by Region (2015-2020)
Table 13. Global Erythropoietin Sales (M Units) Forecast by Region (2021-2026)
Table 14. Global Erythropoietin Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Erythropoietin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Erythropoietin Revenue Share Forecast by Region (2021-2026)
Table 17. Global Erythropoietin (M Units) of Key Companies (2015-2020)
Table 18. Global Erythropoietin Sales Share by Company (2015-2020)
Table 19. Global Erythropoietin Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Erythropoietin Revenue Share by Company (2015-2020)
Table 21. Global Erythropoietin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erythropoietin as of 2019)
Table 22. Global Erythropoietin Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Erythropoietin Manufacturing Sites and Area Served
Table 24. Manufacturers Erythropoietin Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Erythropoietin Players
Table 27. Global Erythropoietin Sales (M Units) by Type (2015-2020)
Table 28. Global Erythropoietin Sales Share by Type (2015-2020)
Table 29. Global Erythropoietin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Erythropoietin Price (M Units) by Type (2015-2020)
Table 31. Global Erythropoietin Sales Share by Type (2021-2026)
Table 32. Global Erythropoietin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Erythropoietin Revenue Share by Type (2021-2026)
Table 34. Global Erythropoietin Price (M Units) by Type (2021-2026)
Table 35. Global Erythropoietin Sales (M Units) by Application (2015-2020)
Table 36. Global Erythropoietin Sales Share by Application (2015-2020)
Table 37. Global Erythropoietin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Erythropoietin Price (M Units) by Application (2015-2020)
Table 39. Global Erythropoietin Sales (M Units) by Application (2021-2026)
Table 40. Global Erythropoietin Sales Share by Application (2021-2026)
Table 41. Global Erythropoietin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Erythropoietin Revenue Share by Application (2021-2026)
Table 43. Global Erythropoietin Price (M Units) by Application (2021-2026)
Table 44. United States Erythropoietin Sales (M Units) by Company (2015-2020)
Table 45. United States Erythropoietin Sales Market Share by Company (2015-2020)
Table 46. United States Erythropoietin Sales (M Units) by Type (2015-2020)
Table 47. United States Erythropoietin Sales Market Share by Type (2015-2020)
Table 48. United States Erythropoietin Sales (M Units) by Application (2015-2020)
Table 49. United States Erythropoietin Sales Market Share by Application (2015-2020)
Table 50. Europe Erythropoietin Sales (M Units) by Company (2015-2020)
Table 51. Europe Erythropoietin Sales Market Share by Company (2015-2020)
Table 52. Europe Erythropoietin Sales (M Units) by Type (2015-2020)
Table 53. Europe Erythropoietin Sales Market Share by Type (2015-2020)
Table 54. Europe Erythropoietin Sales (M Units) by Application (2015-2020)
Table 55. Europe Erythropoietin Sales Market Share by Type (2015-2020)
Table 56. China Erythropoietin Sales (M Units) by Company (2015-2020)
Table 57. China Erythropoietin Sales Market Share by Company (2015-2020)
Table 58. China Erythropoietin Sales (M Units) by Type (2015-2020)
Table 59. China Erythropoietin Sales Market Share by Type (2015-2020)
Table 60. China Erythropoietin Sales (M Units) by Application (2015-2020)
Table 61. China Erythropoietin Sales Market Share by Application (2015-2020)
Table 62. Japan Erythropoietin Sales (M Units) by Company (2015-2020)
Table 63. Japan Erythropoietin Sales Market Share by Company (2015-2020)
Table 64. Japan Erythropoietin Sales (M Units) by Type (2015-2020)
Table 65. Japan Erythropoietin Sales Market Share by Type (2015-2020)
Table 66. Japan Erythropoietin Sales (M Units) by Application (2015-2020)
Table 67. Japan Erythropoietin Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Erythropoietin Sales (M Units) by Company (2015-2020)
Table 69. Southeast Asia Erythropoietin Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Erythropoietin Sales (M Units) by Type (2015-2020)
Table 71. Southeast Asia Erythropoietin Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Erythropoietin Sales (M Units) by Type (2015-2020)
Table 73. Southeast Asia Erythropoietin Sales Market Share by Application (2015-2020)
Table 74. India Erythropoietin Sales (M Units) by Company (2015-2020)
Table 75. India Erythropoietin Sales Market Share by Company (2015-2020)
Table 76. India Erythropoietin Sales (M Units) by Type (2015-2020)
Table 77. India Erythropoietin Sales Market Share by Type (2015-2020)
Table 78. India Erythropoietin Sales (M Units) by Application (2015-2020)
Table 79. India Erythropoietin Sales Market Share by Application (2015-2020)
Table 80. Amgen Corporation Information
Table 81. Amgen Description and Business Overview
Table 82. Amgen Erythropoietin Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Amgen Erythropoietin Product
Table 84. Amgen Recent Development
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Erythropoietin Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Johnson & Johnson Erythropoietin Product
Table 89. Johnson & Johnson Recent Development
Table 90. Roche Corporation Information
Table 91. Roche Description and Business Overview
Table 92. Roche Erythropoietin Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Roche Erythropoietin Product
Table 94. Roche Recent Development
Table 95. Galenica Corporation Information
Table 96. Galenica Description and Business Overview
Table 97. Galenica Erythropoietin Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Galenica Erythropoietin Product
Table 99. Galenica Recent Development
Table 100. Emcure Corporation Information
Table 101. Emcure Description and Business Overview
Table 102. Emcure Erythropoietin Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Emcure Erythropoietin Product
Table 104. Emcure Recent Development
Table 105. Kyowa Hakko Kirin Corporation Information
Table 106. Kyowa Hakko Kirin Description and Business Overview
Table 107. Kyowa Hakko Kirin Erythropoietin Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Kyowa Hakko Kirin Erythropoietin Product
Table 109. Kyowa Hakko Kirin Recent Development
Table 110. 3SBio Corporation Information
Table 111. 3SBio Description and Business Overview
Table 112. 3SBio Erythropoietin Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. 3SBio Erythropoietin Product
Table 114. 3SBio Recent Development
Table 115. Biocon Corporation Information
Table 116. Biocon Erythropoietin Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Biocon Description and Business Overview
Table 118. Biocon Erythropoietin Product
Table 119. Biocon Recent Development
Table . LG Life Sciences Corporation Information
Table . LG Life Sciences Erythropoietin Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . LG Life Sciences Description and Business Overview
Table . LG Life Sciences Erythropoietin Product
Table . LG Life Sciences Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Erythropoietin Distributors List
Table 128. Erythropoietin Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Erythropoietin Product Picture
Figure 2. Global Erythropoietin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Erythropoietin Market Share by Application in 2020 & 2026
Figure 6. Anemia Examples
Figure 7. Kidney Disorders Examples
Figure 8. Others Examples
Figure 9. Global Erythropoietin Sales (M Units) Growth Rate (2015-2026)
Figure 10. Global Erythropoietin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Erythropoietin Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Erythropoietin Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Erythropoietin Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Erythropoietin Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Erythropoietin Sales (M Units) Growth Rate (2015-2026)
Figure 16. Europe Erythropoietin Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Erythropoietin Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Erythropoietin Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Erythropoietin Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Erythropoietin Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Erythropoietin Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Erythropoietin Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Erythropoietin Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Erythropoietin Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Erythropoietin Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Erythropoietin Players Market Share by Revenue in Erythropoietin 2015 & 2019
Figure 27. Erythropoietin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Erythropoietin Revenue Share by Type (2015-2020)
Figure 29. Global Erythropoietin Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Erythropoietin Revenue Share by Application (2015-2020)
Figure 31. Global Erythropoietin Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Erythropoietin Sales Market Share by Type in 2019
Figure 33. United States Erythropoietin Sales Market Share by Type in 2019
Figure 34. Europe Erythropoietin Sales Market Share by Company in 2019
Figure 35. Europe Erythropoietin Sales Market Share by Type in 2019
Figure 36. Europe Erythropoietin Sales Market Share by Application in 2019
Figure 37. China Erythropoietin Sales Market Share by Company in 2019
Figure 38. China Erythropoietin Sales Market Share by Type in 2019
Figure 39. China Erythropoietin Sales Market Share by Application in 2019
Figure 40. Japan Erythropoietin Sales Market Share by Company in 2019
Figure 41. Japan Erythropoietin Sales Market Share by Type in 2019
Figure 42. Japan Erythropoietin Sales Market Share by Application in 2019
Figure 43. Southeast Asia Erythropoietin Sales Market Share by Company in 2019
Figure 44. Southeast Asia Erythropoietin Sales Market Share by Type in 2019
Figure 45. Southeast Asia Erythropoietin Sales Market Share by Application in 2019
Figure 46. India Erythropoietin Sales Market Share by Company in 2019
Figure 47. India Erythropoietin Sales Market Share by Type in 2019
Figure 48. India Erythropoietin Sales Market Share by Application in 2019
Figure 49. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Galenica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Emcure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Kyowa Hakko Kirin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. 3SBio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. LG Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Key Raw Materials Price Trend
Figure 59. Manufacturing Cost Structure of Erythropoietin
Figure 60. Manufacturing Process Analysis of Erythropoietin
Figure 61. Erythropoietin Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Porter's Five Forces Analysis
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
エリスロポエチン薬の世界市場レポート2020 Erythropoietin drugs are also known as hematopoietin. It is a glycoprotein hormone that controls erythropoiesis or production of RBC. They are used in treatment of different diseases like cancer, chronic renal diseases, Global erythropoietin drug market is segmented on the basis of type of product i…- エリスロポエチン（EPO）薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Erythropoietin (EPO) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 10830 million by 2025, from USD 8727.6 million in 2019. The Erythropoi…
- EPOバイオマーカーの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global EPO Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The EPO Biomarkers market report p…
- ダルベポエチンアルファの世界市場レポート2020 A recently published report by QY Research titled Global Darbepoetin Alfa Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate d…
- PEG化タンパク質の世界市場レポート2020 A recently published report by QY Research titled Global PEGylated Proteins Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate…